Smith & Nephew plc (LON:SN)
London · Delayed Price · Currency is GBP · Price in GBX 1,243.00
+8.50 (0.69%)
At close: Jan 27, 2026
Smith & Nephew Employees
Smith & Nephew had 17,349 employees as of December 31, 2024. The number of employees decreased by 1,103 or -5.98% compared to the previous year.
Employees
17,349
Change (1Y)
-1,103
Growth (1Y)
-5.98%
Revenue / Employee
254.96K GBP
Profits / Employee
21.06K GBP
Market Cap
10.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 17,349 | -1,103 | -5.98% |
| Dec 31, 2023 | 18,452 | -560 | -2.95% |
| Dec 31, 2022 | 19,012 | 643 | 3.50% |
| Dec 31, 2021 | 18,369 | 455 | 2.54% |
| Dec 31, 2020 | 17,914 | 277 | 1.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Spire Healthcare Group | 15,703 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Smith & Nephew News
- 6 days ago - Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair - GlobeNewsWire
- 6 days ago - Independence Bank of Kentucky Buys 21 Shares of Smith & Nephew PLC (SNN) - GuruFocus
- 7 days ago - LARGE CAP INTERNATIONAL PORTFOLIO Buys 29,670 Shares of Smith & Nephew PLC (SNN) - GuruFocus
- 7 days ago - International Vector Equity Portfolio Sells 15,299 Shares of Smith & Nephew PLC (SNN) - GuruFocus
- 7 days ago - LARGE CAP INTERNATIONAL PORTFOLIO Buys 226 Shares of Smith & Nephew PLC (SNN) - GuruFocus
- 7 days ago - International Vector Equity Portfolio Sells 99 Shares of Smith & Nephew PLC (SNN) - GuruFocus
- 10 days ago - Lightning Round: Medline is 'unbelievable', it's a buy, says Jim Cramer - CNBC
- 14 days ago - Notable Two Hundred Day Moving Average Cross - SNN - Nasdaq